RTEL1‐TNFRSF6B is a noncoding, readthrough transcript that is subject to NMD (Chang et al., 2007), but it is currently unclear how a change in mRNA decay will affect glioma development. This evidence concerns the gene TNFRSF6B and central nervous system cancer.